Centre for Pharmacoepidemiology and Drug Safety, University of Manchester, Manchester, UK; National Institute for Health Research Greater Manchester Patient Safety Translational Research Centre, University of Manchester, Manchester, UK; Manchester Academic Health Science Centre, Manchester, UK.
Centre for Mental Health and Safety, University of Manchester, Manchester, UK; Manchester Academic Health Science Centre, Manchester, UK.
Lancet Public Health. 2021 Feb;6(2):e124-e135. doi: 10.1016/S2468-2667(20)30288-7. Epub 2021 Jan 11.
The COVID-19 pandemic has adversely affected population mental health. We aimed to assess temporal trends in primary care-recorded common mental illness, episodes of self-harm, psychotropic medication prescribing, and general practitioner (GP) referrals to mental health services during the COVID-19 emergency in the UK.
We did a population-based cohort study using primary care electronic health records from general practices registered on the UK Clinical Practice Research Datalink (CPRD). We included patient records from Jan 1, 2010, to Sept 10, 2020, to establish long-term trends and patterns of seasonality, but focused primarily on the period January, 2019-September, 2020. We extracted data on clinical codes entered into patient records to estimate the incidence of depression and anxiety disorders, self-harm, prescriptions for antidepressants and benzodiazepines, and GP referrals to mental health services, and assessed event rates of all psychotropic prescriptions and self-harm. We used mean-dispersion negative binomial regression models to predict expected monthly incidence and overall event rates, which were then compared with observed rates to assess the percentage reduction in incidence and event rates after March, 2020. We also stratified analyses by sex, age group, and practice-level Index of Multiple Deprivation quintiles.
We identified 14 210 507 patients from 1697 UK general practices registered in the CPRD databases. In April, 2020, compared with expected rates, the incidence of primary care-recorded depression had reduced by 43·0% (95% CI 38·3-47·4), anxiety disorders by 47·8% (44·3-51·2), and first antidepressant prescribing by 36·4% (33·9-38·8) in English general practices. Reductions in first diagnoses of depression and anxiety disorders were largest for adults of working age (18-44 and 45-64 years) and for patients registered at practices in more deprived areas. The incidence of self-harm was 37·6% (34·8-40·3%) lower than expected in April, 2020, and the reduction was greatest for women and individuals aged younger than 45 years. By September, 2020, rates of incident depression, anxiety disorder, and self-harm were similar to expected levels. In Northern Ireland, Scotland, and Wales, rates of incident depression and anxiety disorder remained around a third lower than expected to September, 2020. In April, 2020, the rate of referral to mental health services was less than a quarter of the expected rate for the time of year (75·3% reduction [74·0-76·4]).
Consequences of the considerable reductions in primary care-recorded mental illness and self-harm could include more patients subsequently presenting with greater severity of mental illness and increasing incidence of non-fatal self-harm and suicide. Addressing the effects of future lockdowns and longer-term impacts of economic instability on mental health should be prioritised.
National Institute for Health Research and Medical Research Council.
COVID-19 大流行对人口心理健康产生了不利影响。我们旨在评估英国 COVID-19 紧急情况下初级保健记录中常见精神疾病、自残发作、精神药物处方和全科医生(GP)转介到精神卫生服务的时间趋势。
我们使用英国临床实践研究数据链(CPRD)注册的普通实践中的初级保健电子健康记录进行了基于人群的队列研究。我们从 2010 年 1 月 1 日至 2020 年 9 月 10 日提取患者记录,以建立长期趋势和季节性模式,但主要集中在 2019 年 1 月至 2020 年 9 月期间。我们提取了输入患者记录的临床代码的数据,以估计抑郁症和焦虑症、自残、抗抑郁药和苯二氮䓬类药物处方以及 GP 转介到精神卫生服务的发生率,并评估了所有精神药物处方和自残的事件发生率。我们使用均值分散负二项式回归模型预测预期的每月发病率和总体事件率,然后将其与观察到的比率进行比较,以评估 2020 年 3 月后发病率和事件率的百分比降低。我们还按性别、年龄组和实践层面的多种剥夺五分位数进行了分层分析。
我们从 CPRD 数据库中注册的 1697 家英国普通实践中确定了 14210507 名患者。在 2020 年 4 月,与预期相比,英语普通实践中记录的抑郁症的发病率降低了 43.0%(95%CI 38.3-47.4),焦虑症降低了 47.8%(44.3-51.2),首次抗抑郁药处方降低了 36.4%(33.9-38.8)。对于处于工作年龄(18-44 和 45-64 岁)和登记在资源匮乏地区的实践中的成年人,抑郁症和焦虑症的首次诊断减少幅度最大。自残的发病率比 2020 年 4 月预期低 37.6%(34.8-40.3%),降幅最大的是女性和年龄小于 45 岁的人群。到 2020 年 9 月,抑郁症、焦虑症和自残的发病率与预期水平相似。在北爱尔兰、苏格兰和威尔士,直至 2020 年 9 月,抑郁症和焦虑症的发病率仍比预期低三分之一左右。在 2020 年 4 月,精神卫生服务的转介率不到该季节预期的四分之一(75.3%减少[74.0-76.4])。
初级保健记录中精神疾病和自残发生率显著降低的后果可能包括随后出现更严重精神疾病的患者人数增加,以及非致命性自残和自杀的发生率增加。应该优先解决未来封锁和经济不稳定对精神健康的长期影响。
英国国家卫生研究所和医学研究委员会。